The genetic reconstruction of BCG as a new immunotherapeutic tool
- 31 December 1997
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 15 (12) , 512-517
- https://doi.org/10.1016/s0167-7799(97)01134-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Long‐Lasting Immune Response Induced by Recombinant Bacillus Calmette–Guérin (BCG) Secretion SystemScandinavian Journal of Immunology, 1996
- A stableEscherichia coli-mycobacteria shuttle vector ‘pSO246’ inMycobacterium bovisBCGFEMS Microbiology Letters, 1996
- Mercury resistance as a selective marker for recombinant mycobacteriaMicrobiology, 1995
- Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literatureJAMA, 1994
- Construction and use of integrative vectors to express foreign genes in mycobacteriaMolecular Microbiology, 1993
- Superinfection immunity of mycobacteriophage L5: applications for genetic transformation of mycobacteriaMolecular Microbiology, 1993
- Stable integration and expression of the Plasmodium falciparum circumsporozoite protein coding sequence in mycobacteriaMolecular and Biochemical Parasitology, 1993
- Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef proteinGene, 1991
- Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccinesNature, 1991
- Vaccines for the Third WorldNature, 1989